|
Production of T-cells using engineered soluble DLL4 ligands
Production of T cells using engineered soluble DLL4 ligands
Background
Chimeric Antigen Receptor T-cell (CAR T-cell) therapies are a therapeutic tool for the treatment of several types of cancers, most notably lymphomas and leukemia. Healthy T cells are taken from the patient’s blood, cultured in the laboratory to induce differentiation, and...
Published: 3/26/2026
|
Updated: 11/20/2024
|
Inventor(s): Rubul Mout, Ran Jing, George Daley, Stephen Blacklow, David Baker, Emily Egan
Keywords(s):
Category(s): Technology Classifications > Invention Type > Therapeutics > Cell Therapy, Technology Classifications > Disease Area > Immunology, Technology Classifications > Disease Area > Hematology
|
